Yale University

Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative.

TitleIntegration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative.
Publication TypeJournal Article
Year of Publication2011
AuthorsWeiss, Linda, Julie Netherland, James E. Egan, Timothy P. Flanigan, David A. Fiellin, Ruth Finkelstein, and Frederick L. Altice
Corporate AuthorsBHIVES Collaborative
JournalJournal of acquired immune deficiency syndromes (1999)
Volume56 Suppl 1
PaginationS68-75
Date Published2011 Mar 1
ISSN1944-7884
KeywordsAmbulatory Care, Anti-HIV Agents, Buprenorphine, Delivery of Health Care, Integrated, Health Resources, Health Services Needs and Demand, HIV Infections, Humans, Naloxone, Narcotic Antagonists, Opiate Substitution Treatment, Opioid-Related Disorders, Primary Health Care, Substance Abuse Treatment Centers, United States
AbstractReplication of effective practices requires detailed descriptions of implementation processes, barriers and facilitators, and lessons learned. The experiences of physicians leading the Buprenorphine HIV Evaluation and Support initiative provides valuable information for other HIV providers seeking to integrate medication-assisted treatment services into HIV clinical care.
DOI10.1097/QAI.0b013e31820a8226
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links